Tax burden likely to increase on medical device in GST regime

IANS  |  Kolkata 

The medical device industry expects the load in the Goods and Services (GST) regime to increase, which will result in a higher cost burden on patients, an official said on Wednesday.

"The medical device sector can expect a higher burden due to the proposed rates, subsequently resulting in a higher cost burden to the patients," said Medical Technology Association of India's (MTaI) Board Member Sanjay Bhutani.

He said at the existing indirect regime, the embedded rate approximately comes to 7.5 per cent and 10.7 per cent after considering countervailing duty, central sales tax, value added (VAT), Octroi, entry etc.

In the regime, the rate was pegged at 12 per cent.

"The medical devices including surgical instruments, therefore, will roughly have an additional burden of 4.5 per cent to 1.3 per cent," he said.

Countervailing duty is levied at the first point that is at the import price while central sales is imposed on the billing price from the company to the distributor. VAT is levied at the value at which the goods are finally sold to customers.

According to Bhutani, it was earlier expected that the burden would ease with the introduction of as the uniform indirect regime would subsume all the taxes.

--IANS

bdc/in/vm

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Tax burden likely to increase on medical device in GST regime

The medical device industry expects the tax load in the Goods and Services Tax (GST) regime to increase, which will result in a higher cost burden on patients, an official said on Wednesday.

The medical device industry expects the load in the Goods and Services (GST) regime to increase, which will result in a higher cost burden on patients, an official said on Wednesday.

"The medical device sector can expect a higher burden due to the proposed rates, subsequently resulting in a higher cost burden to the patients," said Medical Technology Association of India's (MTaI) Board Member Sanjay Bhutani.

He said at the existing indirect regime, the embedded rate approximately comes to 7.5 per cent and 10.7 per cent after considering countervailing duty, central sales tax, value added (VAT), Octroi, entry etc.

In the regime, the rate was pegged at 12 per cent.

"The medical devices including surgical instruments, therefore, will roughly have an additional burden of 4.5 per cent to 1.3 per cent," he said.

Countervailing duty is levied at the first point that is at the import price while central sales is imposed on the billing price from the company to the distributor. VAT is levied at the value at which the goods are finally sold to customers.

According to Bhutani, it was earlier expected that the burden would ease with the introduction of as the uniform indirect regime would subsume all the taxes.

--IANS

bdc/in/vm

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22